Management of diabetic nephropathy: Recent progress and future perspective
Data up to Jan 2025
Total Citations Per Year
Abstract
References (144)
A New Equation to Estimate Glomerular Filtration Rate
2009 • 21,756 citations
Biochemistry and molecular cell biology of diabetic complications
2001 • 8,707 citations
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
2008 • 7,044 citations
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 • 5,296 citations
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 • 4,328 citations
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 • 4,169 citations
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 • 3,511 citations
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 • 3,390 citations
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 • 3,163 citations
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 • 2,931 citations
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
2007 • 1,978 citations
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
1984 • 1,939 citations
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
2003 • 1,767 citations
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
1982 • 1,683 citations
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
1984 • 1,603 citations
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 • 1,549 citations
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
2014 • 1,544 citations
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
2008 • 1,539 citations
Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy
2000 • 1,468 citations
Cellular and molecular mechanisms of renal fibrosis
2011 • 1,220 citations
Standards of Medical Care in Diabetes—2007
2006 • 1,166 citations
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
2008 • 1,098 citations
Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease
2004 • 1,060 citations
Nephropathy in Diabetes
2004 • 1,040 citations
Preventing Microalbuminuria in Type 2 Diabetes
2004 • 1,000 citations
Familial Clustering of Diabetic Kidney Disease
1989 • 991 citations
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
1999 • 973 citations
Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy
2003 • 951 citations
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
2011 • 949 citations
EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY
1983 • 884 citations
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
1982 • 772 citations
Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
2008 • 740 citations
Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes
2002 • 721 citations
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
1975 • 717 citations
Inflammation and the pathogenesis of diabetic nephropathy
2012 • 687 citations
Effect of lipid reduction on the progression of renal disease: A meta-analysis
2001 • 669 citations
Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
1995 • 666 citations
Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus
2003 • 595 citations
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion
1982 • 591 citations
Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI Formulas in Relation to GFR, Age, and Body Size
2010 • 582 citations
Contribution of Polyol Pathway to Diabetes-Induced Oxidative Stress
2003 • 569 citations
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
1987 • 551 citations
Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
2011 • 537 citations
NF-κB in Renal Inflammation
2010 • 520 citations
The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus
2000 • 488 citations
Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes*1
1993 • 448 citations
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
2000 • 436 citations
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study
2004 • 420 citations
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
2004 • 395 citations
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy
2010 • 377 citations
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study
1992 • 334 citations
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
2009 • 334 citations
Oxidative stress in early diabetic nephropathy: fueling the fire
2010 • 330 citations
Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors?
2001 • 328 citations
Detection of Renal Function Decline in Patients with Diabetes and Normal or Elevated GFR by Serial Measurements of Serum Cystatin C Concentration
2005 • 327 citations
Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data
2001 • 302 citations
Renoprotective role of the vitamin D receptor in diabetic nephropathy
2007 • 296 citations
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
2005 • 293 citations
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients
2002 • 290 citations
Low Glomerular Filtration Rate in Normoalbuminuric Type 1 Diabetic Patients
2003 • 290 citations
Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.
1999 • 285 citations
Pirfenidone for Diabetic Nephropathy
2011 • 285 citations
Glomerular Structure in Nonproteinuric IDDM Patients With Various Levels of Albuminuria
1994 • 276 citations
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
2009 • 276 citations
Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas
1999 • 273 citations
Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor
1973 • 262 citations
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)
2005 • 255 citations
Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
2008 • 253 citations
Pathogenesis of diabetic nephropathy
2001 • 250 citations
Renal disease and hypertension in non–insulin-dependent diabetes mellitus
1999 • 245 citations
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes
2009 • 245 citations
Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy
2007 • 237 citations
Alternatively Spliced Variant of Smad2 Lacking Exon 3
1999 • 235 citations
Protein restriction for diabetic renal disease
2007 • 232 citations
Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria
2004 • 221 citations
Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
2011 • 221 citations
The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy
2011 • 209 citations
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
2007 • 208 citations
Effective Postponement of Diabetic Nephropathy With Enalapril in Normotensive Type 2 Diabetic Patients With Microalbuminuria
1997 • 199 citations
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
2001 • 196 citations
Genetic Factors in Diabetic Nephropathy
2007 • 192 citations
Antioxidants in the Treatment of Diabetes
2011 • 192 citations
Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy
2008 • 192 citations
Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
2010 • 191 citations
Systematic review on urine albumin testing for early detection of diabetic complications
2005 • 190 citations
Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients
2002 • 190 citations
The role of protein kinase C activation in diabetic nephropathy
2007 • 187 citations
Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?
2008 • 172 citations
Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients
1993 • 169 citations
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
2011 • 163 citations
Fenofibrate
2007 • 163 citations
Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy
1998 • 163 citations
Markers of Diabetic Nephropathy
1998 • 156 citations
Microalbuminuria and cardiovascular risk
2004 • 149 citations
Biomarkers in diabetic nephropathy: Present and future
2014 • 144 citations
Proximal tubular basement membrane width in insulin-dependent diabetes mellitus
1998 • 143 citations
Pyridorin in Type 2 Diabetic Nephropathy
2011 • 140 citations
Renal findings in patients with short-term type 2 diabetes.
1996 • 133 citations
Comparison of the Effects of Vitamins and/or Mineral Supplementation on Glomerular and Tubular Dysfunction in Type 2 Diabetes
2005 • 132 citations
Prevalence of hypertension in Type 1 (insulin-dependent) diabetes mellitus
1990 • 131 citations
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4
1998 • 127 citations
Genetics of Kidneys in Diabetes (GoKinD) Study
2006 • 123 citations
Suppressing renal NADPH oxidase to treat diabetic nephropathy
2007 • 104 citations
Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies
2008 • 103 citations
Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate
2005 • 96 citations
Genome-Wide Scan for Estimated Glomerular Filtration Rate in Multi-Ethnic Diabetic Populations
2007 • 94 citations
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
2007 • 91 citations
Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study
2005 • 90 citations
Effect of Cerivastatin on Urinary Albumin Excretion and Plasma Endothelin-1 Concentrations in Type 2 Diabetes Patients with Microalbuminuria and Dyslipidemia
2001 • 90 citations
Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
2009 • 86 citations
Pancreas Transplantation in Type 1 Diabetes
2004 • 83 citations
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.
1998 • 81 citations
Effects of Long-term Enalapril Treatment on Persistent Microalbuminuria in Normotensive Type 2 Diabetic Patients: Results of a 4-year, Prospective, Randomized Study
1996 • 79 citations
Diabetic nephropathy: a disorder of oxygen metabolism?
2009 • 77 citations
A Randomized Trial of Low-Protein Diet in Type 1 and in Type 2 Diabetes Mellitus Patients With Incipient and Overt Nephropathy
2005 • 76 citations
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients
2004 • 75 citations
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 • 75 citations
Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria
1995 • 74 citations
Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice
2006 • 73 citations
Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus.
2001 • 72 citations
Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control.
1986 • 71 citations
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group*
2005 • 63 citations
Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes
2006 • 61 citations
A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and Congeners
2005 • 60 citations
Insights into the Regulation of Renal Hemodynamic Function in Diabetic Mellitus
2008 • 58 citations
The Role of Transforming Growth Factor-Beta in Diabetic Nephropathy
2014 • 54 citations
Podocytes as Target of Vitamin D
2011 • 53 citations
Glomerular Hyperfiltration in Human Diabetes
1994 • 47 citations
Microalbuminuria is not rare before 5 years of IDDM
1994 • 44 citations
The Kidney and Hypertension in Diabetes Mellitus
1988 • 44 citations
Novel aldose reductase inhibitors: a patent survey (2006 – present)
2012 • 44 citations
Eight-Month Correction of Hyperglycemia in Insulin-dependent Diabetes Mellitus Is Associated with a Significant and Sustained Reduction of Urinary Albumin Excretion Rates in Patients with Microalbuminuria
1985 • 43 citations
Polyunsaturated Fatty Acid Consumption May Play a Role in the Onset and Regression of Microalbuminuria in Well-Controlled Type 1 and Type 2 Diabetic People
2004 • 42 citations
Probucol delays progression of diabetic nephropathy
2005 • 40 citations
The Podocyte: A Major Player in the Development of Diabetic Nephropathy?
2005 • 38 citations
Treating diabetic nephropathy—still an unresolved issue
2012 • 38 citations
Activators and inhibitors of lens aldose reductase.
1971 • 37 citations
A Novel C–C Chemokine Receptor 2 Antagonist Prevents Progression of Albuminuria and Atherosclerosis in Mouse Models
2012 • 37 citations
Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients
2005 • 29 citations
Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects
2003 • 28 citations
Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy
1997 • 19 citations
Hyperfiltration in patients with type I diabetes mellitus: a prevalence study.
1998 • 16 citations
The pathogenesis of diabetic nephropathy
2003 • 7 citations
[Field, a randomized clinical trial of cardiovascular prevention with fenofibrate in type 2 diabetes].
2005 • 3 citations